SOPHARMA AD: Current report 19 UPF Doverie 4.155% 12022014 ENG

opublikowano: 2014-02-12 10:57

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_19_UPF_Doverie_4.155%_12022014_ENG.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 19 / 2014
Date of issue: 2014-02-12
Short name of the issuer
SOPHARMA AD
Subject
Current report 19 UPF Doverie 4.155% 12022014 ENG
Official market - legal basis
Art. 70 pkt 1 Ustawy o ofercie - nabycie lub zbycie znacznego pakietu akcji
Unofficial market - legal basis
Contents of the report:
Sopharma AD (the “Company") announces that on 11 February 2014 the Company received a notification for the sale of 3 424 005 shares by UPF Doverie. After the transaction the share of UPF Doverie in the capital of Sopharma AD decreased to 4,155 %.
The registration date of the transaction in the Central Depository AD, Sofia is 6 February 2014.
Annexes
File Description
Current report 19 UPF Doverie 4.155% 12022014 ENG.docCurrent report 19 UPF Doverie 4.155% 12022014 ENG.doc Current report 19 UPF Doverie 4.155% 12022014 ENG

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2014-02-12 Ognian Donev Executive director